00000000nam 22000008i 4500
0019.910838
003CaOODSP
00520230316144602
006m     o  d f      
007cr |n|||||||||
008220503t20222022onca    o    f000 0 eng d
020 |a9780660433806
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aNR16-388/2022E-PDF
24500|aWhat is commissioning, qualification and validation?
264 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c[2022]
264 4|c©2022
300 |a1 online resource (2 unnumbered pages) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Qu'est-ce que le processus de mise en service, qualification et validation?
650 0|aPharmaceutical industry|xLicenses|zCanada.
650 0|aDrug approval|zCanada.
650 0|aVaccines|zCanada.
7102 |aNational Research Council Canada, |eissuing body.
77508|tQu'est-ce que le processus de mise en service, qualification et validation?|w(CaOODSP)9.910840
7760#|tWhat is commissioning, qualification and validation?|w(CaOODSP)9.910839
85640|qPDF|s419 KB|uhttps://publications.gc.ca/collections/collection_2023/cnrc-nrc/NR16-388-2022-eng.pdf